Botfield; Martyn

Patent Applications and Registrations

Patent applications and USPTO patent grants for Botfield; Martyn.The latest application filed is for "pharmaceutical composition and administrations thereof".

Company Profile

2.16.31

Botfield; Martyn - Concord MA
Botfield; Martyn - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Composition And Administrations Thereof App 20210023070 - Rowe; William ; et al.	2021-01-28
Pharmaceutical composition and administrations thereof Grant 10,646,481 - Rowe , et al.	2020-05-12
Pharmaceutical Composition And Administrations Thereof App 20170087144 - ROWE; WIlliam ; et al.	2017-03-30
Modulators of cystic fibrosis transmembrane conductance regulator Grant 8,999,976 - Binch , et al. April 7, 2	2015-04-07
Modulators of cystic fibrosis transmembrane conductance regulator Grant 8,969,382 - Binch , et al. March 3, 2	2015-03-03
Modulators Of Atp-binding Cassette Transporters App 20140343098 - Sheth; Urvi ; et al.	2014-11-20
Pharmaceutical Composition and Administrations Thereof App 20140315948 - Rowe; William ; et al.	2014-10-23
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20140303204 - Binch; Hayley ; et al.	2014-10-09
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20140235625 - Binch; Hayley ; et al.	2014-08-21
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator App 20140228399 - Binch; Hayley ; et al.	2014-08-14
Modulators of cystic fibrosis transmembrane conductance regulator Grant 8,785,640 - Binch , et al. July 22, 2	2014-07-22
Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-- (trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide App 20140113933 - Zhang; Beili ; et al.	2014-04-24
Pharmaceutical Composition and Administrations Thereof App 20140112988 - Rowe; William ; et al.	2014-04-24
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20140088141 - Binch; Hayley ; et al.	2014-03-27
Modulators of cystic fibrosis transmembrane conductance regulator Grant 8,633,189 - Binch , et al. January 21, 2	2014-01-21
Modulators of ATP-binding cassette transporters Grant 8,614,327 - Sheth , et al. December 24, 2	2013-12-24
Modulators of cystic fibrosis transmembrane conductance regulator Grant 8,604,203 - Binch , et al. December 10, 2	2013-12-10
Modulators of cystic fibrosis transmembrane conductance regulator Grant 8,598,205 - Binch , et al. December 3, 2	2013-12-03
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator App 20130303570 - Binch; Hayley ; et al.	2013-11-14
Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5- -(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide App 20130231368 - Zhang; Beili ; et al.	2013-09-05
Modulators of cystic fibrosis transmembrane conductance regulator Grant 8,513,282 - Binch , et al. August 20, 2	2013-08-20
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20130196983 - Binch; Hayley ; et al.	2013-08-01
Modulators of ATP-Binding Cassette Transporters App 20130165442 - Sheth; Urvi ; et al.	2013-06-27
Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5- -(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide Grant 8,436,014 - Zhang , et al. May 7, 2	2013-05-07
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator App 20130040986 - Binch; Hayley ; et al.	2013-02-14
Modulators of cystic fibrosis transmembrane conductance regulator Grant 8,367,660 - Binch , et al. February 5, 2	2013-02-05
Pharmaceutical Composition and Administrations Thereof App 20120258983 - Rowe; William ; et al.	2012-10-11
Pharmaceutical Composition And Administrations Thereof App 20120220625 - Rowe; William ; et al.	2012-08-30
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator App 20120208841 - Binch; Hayley ; et al.	2012-08-16
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator App 20110257223 - Goor; Fredrick Van ; et al.	2011-10-20
Pharmaceutical Composition And Administrations Thereof App 20100256184 - Rowe; William ; et al.	2010-10-07
Modulators of ATP-Binding Cassette Transporters App 20100184739 - Sheth; Urvi ; et al.	2010-07-22
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20100168094 - Binch; Hayley ; et al.	2010-07-01
Solid Forms Of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5- -(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide App 20100130547 - Zhang; Beili ; et al.	2010-05-27
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20100113509 - Binch; Hayley ; et al.	2010-05-06
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator App 20100113508 - Binch; Hayley ; et al.	2010-05-06
Pharmaceutical composition and administration thereof App 20100074949 - Rowe; William ; et al.	2010-03-25
Biomarkers for Monitoring Impdh Pathway Inhibition App 20080318803 - Jain; Jugnu ; et al.	2008-12-25
Acyclic piperidine derivatives Grant 6,949,655 - Lauffer , et al. September 27, 2	2005-09-27
Quantification and site-specific profiling of protein phosphorylation App 20050074824 - Botfield, Martyn ; et al.	2005-04-07
Modulators of the cholesterol biosynthetic pathway App 20030191110 - Botfield, Martyn ; et al.	2003-10-09
Acyclic piperazine and piperidine derivatives App 20030191117 - Lauffer, David ; et al.	2003-10-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.